A Polygenic Risk Score May Predict Future Breast Cancer in Patients With Early-stage Diagnoses
Patients diagnosed with abnormal breast cells were more likely to receive a later diagnosis of breast cancer if their...
Search/Filter
Loading...
Real-world Data Shows Teclistamab Can Benefit Many Multiple Myeloma Patients Who Would Have Been Ineligible for Pivotal Trial
Retrospective study revealed efficacy of the bispecific T-cell engager in patients with high-risk, heavily pretreated multiple myeloma, including after...
U.S. Uterine Cancer Incidence and Mortality Rates Expected to Significantly Increase by 2050
Black women may face disproportionately higher rates than white women PHILADELPHIA – Uterine cancer incidence and mortality rates are...
Incidence of Several Early-onset Cancers Increased Between 2010 and 2019
The largest increases were observed for breast, colorectal, endometrial, pancreatic, and kidney cancers PHILADELPHIA – In the United States,...
Some Patients May Experience Durable Disease Control Even After Discontinuing Immune Checkpoint Inhibitors for Side Effects
PHILADELPHIA – A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy...
Targeting FGFR2 May Prevent or Delay Some KRAS-mutated Pancreatic Cancers
The preclinical study has implications for pancreatic cancer interception efforts PHILADELPHIA – Precancerous pancreatic lesions and some pancreatic ductal...
Certain Genetic Alterations May Contribute to the Primary Resistance of Colorectal and Pancreatic Cancers to KRAS G12C Inhibitors
PHILADELPHIA – Colorectal cancer and pancreatic ductal adenocarcinoma that harbored the KRAS G12C mutation often carried other genetic alterations...
AACR Names Dr. Timothy Yap as Editor-in-Chief of the Journal Clinical Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Timothy A. Yap, MBBS, PhD, as...
Radiation Plus Combination Immunotherapy May Help Preserve Bladder in Some Patients With Muscle-invasive Bladder Cancer
PHILADELPHIA – Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab...
Dr. Daniel Nomura Selected as Editor-in-Chief of the AACR Journal Molecular Cancer Therapeutics
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Daniel K. Nomura, PhD, as editor-in-chief...